Revisor Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
3,075
-66
-2% -$22.6K 0.27% 95
2026
Q1
$1.11M Buy
3,141
+34
+1% +$12.1K 0.31% 87
2025
Q4
$1.05M Buy
3,107
+1,543
+99% +$489K 0.28% 87
2025
Q3
$462K Buy
1,564
+25
+2% +$7.25K 0.16% 137
2025
Q2
$462K Buy
+1,539
New +$436K 0.17% 145

Other funds holding AMGN

Revisor Wealth Management's AMGN Position: Q2 2026 in Review

Revisor Wealth Management reduced its Amgen (AMGN) stake by 2.1% in Q2 2026, selling an estimated $22.6K and leaving 3,075 shares worth $1.11M. The position accounts for 0.27% of the portfolio, ranked #95.

Revisor Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Revisor Wealth Management held 3,075 shares of Amgen worth $1.11M as of Q2 2026.
  • Revisor Wealth Management sold 66 Amgen shares in Q2 2026, an estimated $22.6K.
  • Amgen made up 0.27% of Revisor Wealth Management's portfolio in Q2 2026, its #95 holding.
  • Revisor Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.